Convalescent Plasma Therapy: A Treatment of Choice for COVID-19 during Current Pandemic

The severe acute respiratory syndrome coronavirus 2 which is the source of pandemic disease 2019 has engulfed almost whole world. This virus was first reported in Wuhan city (China) December 2019. Since discovery virus, till today researchers and scientists have been working to develop new vaccines or therapeutic agents against 2. However, thus far no vaccine emerged that can be approved treat prevent Due lack specific preventative options for treatment 2019, use convalescent plasma therapy may great benefit current situation. Previous immune resulted successful hemagglutinin type 1 neuraminidase influenza Middle East epidemics. In scenario raised by applied successfully among many patients across various regions. article presents an up-to-date review existing literature on recovery through as a choice, safety its efficacy, possibility challenges